Related Experiment Video
Updated: Mar 30, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
MiR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer
Cai-Ping Chen1, Zong-Lin Sun2, Xiang Lu1
1Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Jiaxing College, Jiaxing, Zhejiang 314001, P.R. China.
Abstract:
Breast cancer is one of the most common malignant tumors among females, and can seriously affect the physical and mental health and even threaten the lives of women. Recently, research has demonstrated that microRNAs (miRNAs), as a new method of regulation, have been shown to have oncogenic and tumor‑suppressive functions in human breast cancer. Detection of their expression may lead to the identification of novel markers for breast cancer. In the present study, we firstly detected miR‑340 expression and found lower expression of miR‑340 in 6 human breast cancer cell lines by using RT‑qPCR. Then by using wound healing assay and Transwell migration and invasion experiments, we focused on the role of miR-340 in the regulation of tumor cell migration and invasion, exploring the relationship between them. The results revealed that induction of miR‑340 expression was able to suppress tumor cell migration and invasion, whereas knockdown of miR‑340 expression promoted breast cancer cell migration and invasion. At the gene level, MYO10 (myosin X), as a direct miR‑340 target gene, mediated the cell migration and invasion. Finally, we verified our research further at the tissue specimen level and in animal experiments. In brief, miR‑340 plays an important role in breast cancer progression. Thus, miR‑340 may be further explored as a novel biomarker for breast cancer metastasis and prognosis, and potentially a therapeutic target.
Insights
MicroRNA-340 (miR-340) is downregulated in breast cancer, suppressing tumor cell migration and invasion. Its target gene, MYO10, mediates these effects, suggesting miR-340 as a potential biomarker and therapeutic target for breast cancer metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer is a leading cause of mortality in women.
- MicroRNAs (miRNAs) are key regulators with dual roles in cancer.
- Identifying novel biomarkers for breast cancer progression is crucial.
Purpose of the Study:
- To investigate the role of miR-340 in breast cancer.
- To determine miR-340's effect on tumor cell migration and invasion.
- To identify miR-340's downstream targets involved in breast cancer metastasis.
Main Methods:
- Quantitative reverse transcription PCR (RT-qPCR) for miR-340 expression analysis.
- Wound healing and Transwell assays for cell migration and invasion.
- Analysis of miR-340 target genes, including MYO10.
- Validation in tissue specimens and animal models.
Main Results:
- miR-340 expression was significantly lower in breast cancer cell lines.
- Upregulation of miR-340 suppressed, while knockdown promoted, cell migration and invasion.
- MYO10 was identified as a direct target gene mediating these effects.
- Findings were corroborated in tissue and animal studies.
Conclusions:
- miR-340 plays a critical role in inhibiting breast cancer progression.
- miR-340 acts as a tumor suppressor by targeting MYO10.
- miR-340 holds potential as a biomarker for breast cancer metastasis and prognosis, and as a therapeutic target.
Related Concept Videos
MicroRNAs
MicroRNAs
Cancer Cell Migration through Invadopodia
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
Cell Migration
Cell Migration

